Clinical trials
Phase 3 Acquired Immunodeficiency Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
239 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 6 |
| 2003 | 4 |
| 2004 | 10 |
| 2005 | 5 |
| 2006 | 10 |
| 2007 | 11 |
| 2008 | 8 |
| 2009 | 7 |
| 2010 | 10 |
| 2011 | 15 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 11 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 203 |
| Unknown status | 10 |
| Recruiting | 8 |
| Terminated | 7 |
| Active, not recruiting | 5 |
| Withdrawn | 4 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 36 |
| ViiV Healthcare | 24 |
| Gilead Sciences | 12 |
| Merck Sharp & Dohme LLC | 9 |
| Bristol-Myers Squibb | 8 |
| Harvard School of Public Health (HSPH) | 6 |
| Pfizer | 6 |
| Glaxo Wellcome | 5 |
| Hoffmann-La Roche | 5 |
| GlaxoSmithKline | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 239 |
| HIV Infections | 147 |
| AIDS-Related Complex | 27 |
| Infections | 20 |
| Pneumonia, Pneumocystis | 18 |
| AIDS-Related Opportunistic Infections | 15 |
| Hepatitis C | 8 |
| Sarcoma, Kaposi | 7 |
| Sexually Transmitted Diseases | 6 |
| Cytomegalovirus Infections | 5 |
Trials
Showing 51 to 75 of 239. Each trial links to its page on Pharma Observatory.
139 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.